Skip to content

Clinical trials

Phase 2 COVID-19 trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Phase 2 Country / region: Russia Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
202015
20215
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Unknown status5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
AB Science1
Apeiron Biologics1
Apogenix AG1
Biotest1
Chong Kun Dang Pharmaceutical1
Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products1
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia1
Federal State Budgetary Institution, Pulmonology Scientific Research Institute1
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1921
Coronavirus Infections5
Community-Acquired Pneumonia1
Pneumonia1
Pneumonia, Viral1
Pulmonary Fibrosis1
Respiratory Aspiration1
Respiratory Distress Syndrome1
Severe Acute Respiratory Syndrome1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.